aTyr Pharma Inc reports results for the quarter ended in September - Earnings Summary

aTyr Pharma

10/11/2022 22:02

* aTyr Pharma Inc  LIFE.OQ  reported a quarterly adjusted
loss
of 46 cents​​ per share for the quarter ended in September. The
mean expectation of seven analysts for the quarter was for a
loss of 46 cents per share.
    * Reported revenue was zero​; analysts expected $333.33
thousand. 
    * aTyr Pharma Inc's reported EPS for the quarter was a loss
of 46
cents​.
    * The mean earnings estimate of analysts had fallen by
about 16.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * aTyr Pharma Inc shares had fallen by 24.3% this
quarter and
lost 69.6% so far this year.
    * The company reported a quarterly loss of $13.24 million.
    * Wall Street's median 12-month price target for aTyr Pharma
Inc
is $20.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.46          -0.46          Met
 Jun. 30 2022      -0.38          -0.44          Missed
 Mar. 31 2022      -0.33          -0.44          Missed
 Dec. 31 2021      -0.28          -0.31          Missed